List view / Grid view

Dr. Christian Schetter

 

news

Rigontec GmbH Appoints Dr. Christian Schetter as CEO

Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics…

5 February 2015 | By Rigontec GmbH

Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, announces the appointment of Dr. Christian Schetter as CEO...